Search
Zai Lab Ltd
ZLABAdd to Watchlist
26.440USD
+0.030+0.11%
Close 09-23 16:00（ET）
2.97BMarket Cap
LossP/E TTM
Zai Lab Ltd (ZLAB) Stock Price Target & Forecast
Analyst Rating
Based on 12 analysts giving stock ratings to Zai Lab Ltd in the past month.
Buy
3 Strong Buy
8 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
32.880USD+24.50%
ZLAB Analyst Recommendation Trends
In the current month, ZLAB has received 8 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. ZLAB average Analyst price target in the last month is 32.880.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
3
3
3
3
3
3
3
3
8
8
8
8
8
8
8
8
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
12
12
12
12
12
12
12
ZLAB Analyst Rating for Peer Comparison
Updated: Sep 23, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Amgen Inc
AMGN
4
12
18
2
1
37
Biogen Inc
BIIB
7
17
12
1
0
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Financial Forecasting
Based on analysts' estimates, ZLAB EPS is projected to reach -0.577 in FY2026Q3, following reported EPS of -0.455 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.34
-0.50
-0.62
-0.58
-0.64
Actual
-0.46
-0.46
-0.45
--
--
Surprise
-35.56%
+8.48%
+26.33%
--
--
FAQs
What is Zai Lab Ltd's expected revenue for the next quarter?
Zai Lab Ltd's expected revenue is 108.82M.
What is Zai Lab Ltd's price target?
Analysts forecast that Zai Lab Ltd's price target is USD 32.88, with the highest forecast at USD 50.00 and the lowest forecast at USD 24.25.
How have Zai Lab LtdZLAB's recent earnings per share performed?
The market expectation was USD -0.45, while Zai Lab LtdZLAB's earnings per share (EPS) for the previous quarter was USD -0.46. EPS for the next quarter is expected at USD -0.58.
What is the analyst rating for Zai Lab Ltd?
Based on the ratings of Zai Lab Ltd's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.